Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03655756
What this trial is testing

PDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IV
TuHURA Biosciences, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00412828
What this trial is testing

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage III or Stage IV Melanoma
CuraGen Corporation 117
Large-scale testing (Phase 3)UnknownNCT00052156
What this trial is testing

Vaccine Therapy for Patients With Stage IV Melanoma

Who this might be right for
Malignant Melanoma
CancerVax Corporation 670
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT01245556
What this trial is testing

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 8
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Large-scale testing (Phase 3)WithdrawnNCT00447356
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Who this might be right for
Melanoma (Skin)
Hackensack Meridian Health
Not applicableNo Longer AvailableNCT02147951
What this trial is testing

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen
Early research (Phase 1)Study completedNCT02696356
What this trial is testing

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

Who this might be right for
Melanoma
BrightPath Biotherapeutics 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562129
What this trial is testing

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVInoperable Disease
H. Lee Moffitt Cancer Center and Research Institute 18
Large-scale testing (Phase 3)Ended earlyNCT01013623
What this trial is testing

Stage IV Surgery Versus Best Medical Therapy

Who this might be right for
Stage IV Resectable Melanoma
Saint John's Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00700882
What this trial is testing

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 81
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableLooking for participantsNCT05839912
What this trial is testing

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Who this might be right for
Melanoma
Craig L Slingluff, Jr 66
Early research (Phase 1)UnknownNCT00002781
What this trial is testing

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
Beth Israel Deaconess Medical Center 15
Not applicableUnknownNCT00897481
What this trial is testing

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 1,000
Not applicableStudy completedNCT00897546
What this trial is testing

Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,716
Testing effectiveness (Phase 2)Ended earlyNCT00675727
What this trial is testing

Safety Study of CADI-05 in Patients With Advanced Stage Melanoma

Who this might be right for
Stage III or Stage IV Melanoma
Cadila Pharnmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT01586195
What this trial is testing

Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E

Who this might be right for
Malignant Melanoma
Genentech, Inc. 31
Next Page